Toronto, Ontario--(Newsfile Corp. - June 17, 2025) - Jody Kuzenko, President & Chief Executive Officer, Torex Gold Resources Inc. ("Torex" or the "Company") (TSX: TXG), and her team, joined Dean McPherson, Head, Business Development, Global Mining, Toronto Stock Exchange (TSX), to close the market and celebrate the Company's 15th anniversary of being listed on TSX. Cannot view this video?
Report shines a spotlight on continued leadership in responsible mining (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - June 12, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) today released its 2024 Responsible Gold Mining Report (the "Report") titled Building from Strength, the Company's tenth annual disclosure of its safety, environmental, social and governance performance. The Report can be found on the Company's website at www.torexgold.com.
The average of price targets set by Wall Street analysts indicates a potential upside of 43.1% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
28 Apr 2025 Date | | - Cons. EPS | - EPS |
13 Feb 2025 Date | | - Cons. EPS | - EPS |
31 Oct 2024 Date | | - Cons. EPS | - EPS |
29 Oct 2024 Date | | - Cons. EPS | - EPS |
8 Aug 2024 Date | | - Cons. EPS | - EPS |
28 Apr 2025 Date | | - Cons. EPS | - EPS |
13 Feb 2025 Date | | - Cons. EPS | - EPS |
31 Oct 2024 Date | | - Cons. EPS | - EPS |
29 Oct 2024 Date | | - Cons. EPS | - EPS |
8 Aug 2024 Date | | - Cons. EPS | - EPS |
Medical - Healthcare Information Services Industry | Healthcare Sector | Dr. Serge Saxonov Ph.D. CEO | XDUS Exchange | US88025U1097 ISIN |
US Country | 1,306 Employees | - Last Dividend | - Last Split | 12 Sep 2019 IPO Date |
10x Genomics, Inc. is a prominent life science technology company known for its innovative development and commercialization of instruments, consumables, and software aimed at analyzing biological systems. The company's footprint extends across the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific regions, catering to a diverse clientele that includes academic, government, biopharmaceutical, biotechnology, and other institutions. Originally named 10X Technologies, Inc., it underwent a rebranding to 10x Genomics, Inc. in November 2014. Since its inception in 2012, 10x Genomics has established its headquarters in Pleasanton, California, positioning itself as a leader in the field of genomics and cellular analysis.